Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3274924 | 0.83 | TRPA1 (0.32) | SMN1; SMN2 | |
| SCHEMBL27610746 | 0.81 | SMN1; SMN2 (0.34) | SMN1; SMN2 | |
| SCHEMBL10338316 | 0.79 | SMN1; SMN2 (0.33) | SMN1; SMN2 | |
| SCHEMBL28642158 | 0.79 | SMN1; SMN2 (0.40) | SMN1; SMN2 | |
| SCHEMBL10338313 | 0.79 | SMN1; SMN2 (0.33) | SMN1; SMN2 | |
| SCHEMBL3544856 | 0.77 | CETP (0.33) | — | |
| SCHEMBL9509607 | 0.75 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL28054028 | 0.75 | TP53 (0.37) | — | |
| SCHEMBL23466920 | 0.75 | — | — | |
| SCHEMBL4744556 | 0.75 | KMT2A (0.33) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118222171-A | Nanometer stamping adhesive for improving adhesive force of glass-based circuit and circuit manufacturing method based on glass substrate | 深圳市百柔新材料技术有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117693273-A | Photoelectric device, preparation method thereof and display device | TCL科技集团股份有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-113035408-B | Solar cell grid line slurry and preparation method thereof, and solar cell | 深圳市百柔新材料技术有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-109735168-B | Application of cyclanol as additive in preparation of quantum dot ink, quantum dot ink and preparation method of quantum dot ink | 广东聚华印刷显示技术有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-116035949-B | Oil balance type low-turbidity high-compatibility cosmetic composition | 广州科创材料科技有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-118398276-A | Silver-coated copper slurry, and strong light curing process and application thereof | 华中科技大学温州先进制造技术研究院 | 2024-07-26 | — | — | CN | disclosed |
| CN-118222171-A | Nanometer stamping adhesive for improving adhesive force of glass-based circuit and circuit manufacturing method based on glass substrate | 深圳市百柔新材料技术有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-117693273-A | Photoelectric device, preparation method thereof and display device | TCL科技集团股份有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117545179-A | Conductive glass substrate and preparation method and application thereof | 深圳市百柔新材料技术有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-113035408-B | Solar cell grid line slurry and preparation method thereof, and solar cell | 深圳市百柔新材料技术有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-116035949-A | Oil balance type low-turbidity high-compatibility cosmetic composition | 上海永熙信息科技有限公司 | 2023-05-02 | — | — | CN | disclosed |
| EP-2337544-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | Living Proof, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2008134712-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008070368-A2 | METHODS AND COMPOSITIONS FOR SKIN CARE | LIVING PROOF, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | MMP1, MMP9, MMP17 | SMN1; SMN2 1562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.